Merck/Bio-Techne
Transaction details
The proposed acquisition by Merck KGaA, through its wholly owned subsidiaries EMD Holding Corp. and EMD Holdings NewCo, Inc., of sole control of Bio-Techne has been notified to the Competition and Consumer Protection Commission.
Case details
- Notification date:17 August 2026
- Publication date:19 August 2026
- Economic sector:Manufacturing - C
- Economic sub-sector:Manufacture of pharmaceuticals - C.21
- Outcome:Pending
Timetable
- Current deadline:
- 27 September 2026
Parties Involved
Merck KGaA
Merck KGaA ("Merck") is a global science and technology company headquartered in Darmstadt, Germany. In the State, Merck is active through a number of subsidiaries involved in the manufacture and supply of pharmaceutical products and life science products used in scientific research, drug discovery and biopharmaceutical manufacturing.
Bio-Techne Corporation
Bio-Techne Corporation is a global life sciences company headquartered in Minnesota, United States. The company develops and supplies research reagents, analytical instruments, diagnostic products and spatial biology technologies for use by academic researchers, biopharmaceutical companies and clinical laboratories. In the State, Bio-Techne Corporation operates through Bio-Techne Ireland Limited, which acts as a distribution hub for the group’s products and supplies research and diagnostic products to customers.
Contacts
Aodhán Frain aodhanfrain@ccpc.ie Jack Kelly jackkelly@ccpc.ie
